Sarepta Therapeutics | Driftsresultatet

Operating Profit Endring Dato
Acadia Pharmaceuticals USD 15.21M 19.73M 2024-03
Agios Pharmaceuticals USD -92072000 14.2M 2024-03
Alnylam Pharmaceuticals USD -43435000 72.97M 2024-03
Amgen USD 991M 280M 2024-03
Avrobio USD -7941000 782K 2024-03
Biogen USD 570M 211.1M 2024-03
BioMarin Pharmaceutical USD 78.46M 64.24M 2024-03
Daiichi Sankyo JPY 99.49B 48.46B 2023-12
Eli Lilly USD 2.74B 347.8M 2024-03
Gilead Sciences USD -191000000 1.8B 2024-03
Incyte USD 91.35M 95.92M 2024-03
Insmed USD -157405000 20.87M 2024-03
Ionis Pharmaceuticals USD -149513000 170.19M 2024-03
Moderna USD -1266000000 1.27B 2024-03
Neurocrine Biosciences USD 105.3M 35.9M 2024-03
Pfizer USD 4.2B 10.75B 2024-03
PTC Therapeutics USD -45553000 86.18M 2024-03
Regeneron Pharmaceuticals USD 758.5M 214.4M 2024-03
Roche Holding CHF 9.76B 3.84B 2023-06
Sanofi EUR 2.23B 980M 2024-03
Sarepta Therapeutics USD 34.9M 83.25M 2024-03
Ultragenyx Pharmaceutical USD -165347000 43.3M 2024-03
Vertex Pharmaceuticals USD 1.22B 178.1M 2024-03



Sarepta Therapeutics Driftsresultatet - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.